Established in 2018, Chiheal Biomed is situated in the Gulou District of Nanjing. Founded collaboratively by well-known experts in the industry, we operate as a CXO company specializing in providing pharmaceutical R&D technical services.
Guided by a mission that places clinical needs at the forefront, prioritizes innovative R&D, and centers around customer requirements, Chiheal Biomed is dedicated to delivering superior and efficient services to the pharmaceutical industry and a wide-ranging clientele. Our comprehensive services include "enterprise development planning and market value management, product proposal evaluation and pipeline planning, pharmaceutical research, formulation of non-clinical research protocols and project management, clinical research, and regulatory affairs."
Chiheal Biomed, guided by the principle of "Innovation Drives Development," extends its commitment to global clients, offering opportunities for the transfer and collaborative development of impactful Fast-Follow First-in-Class (FIC) innovative drugs. We take pride in delivering a comprehensive, "one-stop" service for innovative drug development, encompassing drug design, synthesis, pharmaceutical development, and clinical research services. Our platforms are designed to cater to the diverse nee
The company, built on a foundation of generic drugs and consistency evaluation services, highlights its specialized and efficient advantages. Our services span various dosage forms, including oral solid formulations, inhalants, topical formulations, eye drops, and injectables.
Our company has established robust technological platforms for fundamental and applied research in Traditional Chinese Medicine (TCM), encompassing theory, key technologies in innovative drugs, and critical technologies in the TCM industry. These platforms are pivotal for conducting foundational and applied research, fostering advancements in TCM and contributing to the development of novel pharmaceuticals.
Led by Dr. Ding, one of the earliest practitioners in peptide drug research in China, our scientific team is dedicated to in-depth exploration in areas such as metabolic diseases, antiviral and antibacterial solutions, immunological disorders, and anticancer therapeutics. We have successfully completed or are currently advancing projects involving peptide drugs, including Terlipressin, Octreotide, Pucakine, Semaglutide, CT130, CT153, and more.
The company offers a range of services, including research initiation, R&D strategic guidance, registration consultation, technical advisory, and documentation review, as well as simulated inspections. With a track record of completing dozens of technical service projects, we have provided guidance to numerous oral solid dosage formulations to successfully undergo Consistency Evaluation studies.
Aikang Pharma focuses its primary operations on Phase I-IV clinical trials and Bioequivalence (BE) studies, specializing in drug clinical research CRO services and comprehensive support for IND, ANDA, and NDA registrations. Our commitment lies in delivering pharmaceutical companies specialized services in drug clinical CRO and regulatory submissions for the Chinese market, expediting the process of product market entry.
Based on the independent project development on the company's pharmaceutical R&D platform, we explore various collaboration models after obtaining phased R&D results. Simultaneously, we establish and offer a MAH-licensed platform to assist partners in bringing their products to market or facilitating collaborations.
We are steadily advancing internationalization which is a long-term development strategy for Chiheal Biomed. The company consistently emphasizes efficient and breakthrough R&D innovation, maintaining a balance between independent R&D and open collaboration. By integrating global resources and strengthening international cooperation on the foundation of endogenous development, Chiheal Biomed is committed to achieving sustainable growth in the global pharmaceutical landscape.
Company address: Room N203, Building A5, No. 199 Mufu East Road, Gulou District, Nanjing City
Contact information:
Mr Min (Business Manager) +86 13913359344 njzh_mzj@chihealbio.com.cn
Mrs Li (Business Manager) +86 18115167072 njzh_ln@chihealbio.com.cn
